Latest News

Pomerantz LLP Files Investor Lawsuit Against Fractyl Health, Inc. – GUTS

LINC LAWSUIT ALERT: Levi & Korsinsky Notifies Lincoln Educational Services Corporation Investors - Lead Plaintiff Deadline November 10, 2026

Pomerantz LLP Announces Commencement of Class Action Lawsuit Against AppLovin Corporation – APP

UraniumX Plans Winter Gravity Program at Murphy Lake as Q4 Assays Approach

Pomerantz LLP Issues Reminder to Shareholders in UWM Holdings Corporation of Class Action Lawsuit – UWMC

C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society (IMS) Annual Meeting

Pomerantz LLP Informs Shareholders of Class Action Filing Against The Simply Good Foods Company – SMPL

Pomerantz LLP Informs Shareholders of Securities Class Action Against HDFC Bank Limited – HDB

Class Action Reminder from Pomerantz LLP for Investors of Replimune Group, Inc. – REPL

Pomerantz LLP Updates Shareholders on Legal Action Brought Against ARS Pharmaceuticals, Inc. – SPRY